2022-LBA-1282-ESGO Identifying women with early-stage cervical cancer at low risk of lymph node metastases, in a large international cohort – A logistic regression analysis, without sharing privacy-sensitive patient data. (27th October 2022)
- Record Type:
- Journal Article
- Title:
- 2022-LBA-1282-ESGO Identifying women with early-stage cervical cancer at low risk of lymph node metastases, in a large international cohort – A logistic regression analysis, without sharing privacy-sensitive patient data. (27th October 2022)
- Main Title:
- 2022-LBA-1282-ESGO Identifying women with early-stage cervical cancer at low risk of lymph node metastases, in a large international cohort – A logistic regression analysis, without sharing privacy-sensitive patient data
- Authors:
- Wenzel, Hans
Hardie, Anna Norberg
Bekkers, Ruud
Falconer, Henrik
Høgdall, Claus
Jensen, Pernille
Lemmens, Valery
Martin, Frank
Moncada-Torres, Arturo
Nijman, Hans
van der Aa, Maaike
Schnack, Tine - Abstract:
- Abstract : Introduction: Standard treatment of early-stage cervical cancer is radical hysterectomy with pelvic lymphadenectomy. However, a generic benefit of systematic lymphadenectomy is questionable, as most women will not have metastatic nodes. This study aimed to classify the most important risk factors of lymph node metastases (pN+) and to identify a group of women at low risk of pN+, in a large cohort of Danish, Swedish and Dutch women, using federated learning. Methods: Women diagnosed with cervical cancer between 2005–2020 were identified from nationwide population-based registries: the Danish Gynaecological Cancer Database, Swedish Quality Registry of Gynaecologic Cancer and Netherlands Cancer Registry. Inclusion criteria were: squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma; FIGO 2009 stage IA2, IB1 and IIA1; treatment with radical hysterectomy and pelvic lymph node assessment. We applied privacy-preserving federated logistic regression to identify risk factors of pN+ ( figure 1 ). Significant factors were used to identify a low-risk group (pN+ &le5%). Results: A total of 3, 606 women were included. The most important risk factors of pN+ were lymphovascular space invasion (LVSI) (odds ratio [OR] 5.16, 95% confidence interval [CI] 4.59–5.79), tumour size 21–40 mm (OR 2.14, 95% CI 1.89–2.43) and depth of invasion &gt10 mm (OR 1.81, 95% CI 1.59–2.08]). Tumours without LVSI, a size ≤20 mm and a depth of invasion ≤10 mm were associated with a low riskAbstract : Introduction: Standard treatment of early-stage cervical cancer is radical hysterectomy with pelvic lymphadenectomy. However, a generic benefit of systematic lymphadenectomy is questionable, as most women will not have metastatic nodes. This study aimed to classify the most important risk factors of lymph node metastases (pN+) and to identify a group of women at low risk of pN+, in a large cohort of Danish, Swedish and Dutch women, using federated learning. Methods: Women diagnosed with cervical cancer between 2005–2020 were identified from nationwide population-based registries: the Danish Gynaecological Cancer Database, Swedish Quality Registry of Gynaecologic Cancer and Netherlands Cancer Registry. Inclusion criteria were: squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma; FIGO 2009 stage IA2, IB1 and IIA1; treatment with radical hysterectomy and pelvic lymph node assessment. We applied privacy-preserving federated logistic regression to identify risk factors of pN+ ( figure 1 ). Significant factors were used to identify a low-risk group (pN+ &le5%). Results: A total of 3, 606 women were included. The most important risk factors of pN+ were lymphovascular space invasion (LVSI) (odds ratio [OR] 5.16, 95% confidence interval [CI] 4.59–5.79), tumour size 21–40 mm (OR 2.14, 95% CI 1.89–2.43) and depth of invasion &gt10 mm (OR 1.81, 95% CI 1.59–2.08]). Tumours without LVSI, a size ≤20 mm and a depth of invasion ≤10 mm were associated with a low risk of pN+ (2%, 95% CI 2–3%) ( table 1 ). Conclusions: LVSI, tumours size and depth of invasion were the most important risk factors of pN+. Based on that, we identified a group at very low risk of pN+, in whom sentinel lymph node mapping should be considered to replace radical pelvic lymphadenectomy. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 32(2022)Supplement 2
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 32(2022)Supplement 2
- Issue Display:
- Volume 32, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 32
- Issue:
- 2
- Issue Sort Value:
- 2022-0032-0002-0000
- Page Start:
- A467
- Page End:
- A468
- Publication Date:
- 2022-10-27
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2022-ESGO.1010 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24609.xml